CAS 95403-16-0

Fórmula: C17H16O5

InChI: InChI=1S/C17H16O5/c1-8-15(20)9(2)17-14(16(8)21)12(19)7-13(22-17)10-3-5-11(18)6-4-10/h3-6,13,18,20-21H,7H2,1-2H3

Chave InChI: DYHOLQACRGJEHX-UHFFFAOYSA-N

SMILES: CC1=C(C(=C2C(=C1O)C(=O)CC(O2)C3=CC=C(C=C3)O)C)O

Farrerol

CAS: 95403-16-0

Oxygen-heterocyclic compound

Fórmula: C₁₇H₁₆O₅

Pureza: ≥ 95.0 % (HPLC)

Cor e Forma: Powder

Peso molecular: 300.31

Ref: 5G-82539

Farrerol

Produto Controlado

CAS: 95403-16-0

Applications Farrerol is a modulator of ERK1/2 activity which regulates occludin expression in cells. This affects tight junctions in human cells which is related to various epidermal skin diseases and ailments.
References Lai-Cheong, J. et al.: J. Invest. Dermatol., 127, 2713 (2007); Li, J. et al.: Eur. J. Pharm., 734, 9 (2014);

Fórmula: C₁₇H₁₆O₅

Cor e Forma: Neat

Peso molecular: 300.31

Ref: TR-F101060

Farrerol

CAS: 95403-16-0

Farrerol is a natural compound that inhibits the angiotensin system and has been shown to have anti-inflammatory effects. It can be used for the treatment of inflammatory diseases, including arthritis, asthma, and psoriasis. Farrerol has also been shown to inhibit the production of collagenase in human serum, which may be due to its ability to suppress the activity of neutrophils. This molecule also has neuroprotective properties and can inhibit neuronal death after injury by inhibiting microglia activation. Farrerol is structurally similar to a polyketide synthase (PKS) intermediate and activates toll-like receptor 4 (TLR4) pathways.

Fórmula: C₁₇H₁₆O₅

Pureza: Min. 95%

Peso molecular: 300.31 g/mol

Ref: 3D-VDA40316